SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: idahoranch1 who wrote (291)12/18/2004 6:41:59 PM
From: kitty2  Read Replies (1) of 371
 
idahoranch1
Do you think there is any real possibility of immu getting a partner and would the partner own cd 22 for its impact on lupus or any disease process.
How can immu keep going if they do not get partner
do they have any other income from selling antibodies
Is there a big market for lupus in terms of potential patients
How do you evaluate the risk/reward ratio with immu stock at 3.50
thank you for your time
also let us say they get a partner today how long is the phase 3? If you could provide an imaginary timeline best case and not so good of a case. Is lupus 100milliom or 500million market or how big
thanks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext